-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Korro Bio, Maintains $25 Price Target

Benzinga·05/13/2025 22:10:40
Listen to the news
Chardan Capital analyst Keay Nakae maintains Korro Bio (NASDAQ:KRRO) with a Buy and maintains $25 price target.